Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cullinan Therapeutics Inc (CGEM)

Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cullinan Therapeutics Inc ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 USA

www.cullinanoncology.com P: 617-410-4650

Description:

Cullinan Oncology Inc. is a biopharmaceutical company. It focused on developing modality-agnostic targeted oncology therapies. Cullinan Oncology Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 1,167,950
Enterprise Value, $K 1,069,520
Shares Outstanding, K 43,066
Annual Sales, $ 0 K
Annual Net Income, $ -153,160 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -23,800 K
EBIT, $ -191,100 K
EBITDA, $ -190,790 K
60-Month Beta 0.33
% of Insider Shareholders 8.82%
% of Institutional Shareholders 86.31%
Float, K 39,268
% Float 91.18%
Short Volume Ratio 0.45

Growth:

1-Year Return 176.38%
3-Year Return -9.18%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.54 on 03/14/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -3.69
EPS Growth vs. Prev Qtr 40.66%
EPS Growth vs. Prev Year 8.47%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CGEM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -32.11%
Return-on-Assets % -30.39%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.81
Book Value/Share 10.61
Interest Coverage -2.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar